| SPECIMEN REQUIREMENTS | |
| Container Type | Random urine |
| Supply Item Number |  1387 |
| Specimen Type | Random urine |
| Preferred Volume | 20 mL |
| Emergency Minimum Volume | 10 mL |
| Collection Procedure | Collect a random urine in a leakproof plastic urine container. |
| Store and Transport | Ambient (room temperature) |
| CPT Codes | 80356, 80365, 80361, (HCPCS G0480) |
| Interface Order Code | 80100.Z202 |
| Billing Code | LCOP9 |
| Test Schedule | Mon-Sat |
| Turnaround Time | 1-3 days |
| Method | Liquid Chromatography Tandem Mass Spectrometry |
| Reference Ranges | | Title | Descriptor | Ranges | Units | | Morphine Confirmation by LC-MS/MS | Not Detected | < 50 | ng/mL | | Oxymorphone Confirmation by LC-MS/MS | Not Detected | < 50 | ng/mL | | Noroxcodone Confirmation by LC-MS/MS | Not Detected | < 50 | ng/mL | | Hydromorphone Confirmation by LC-MS/MS | Not Detected | < 50 | ng/mL | | Codeine Confirmation by LC-MS/MS | Not Detected | < 50 | ng/mL | | Oxycodone Confirmation by LC-MS/MS | Not Detected | < 50 | ng/mL | | Hydrocodone Confirmation by LC-MS/MS | Not Detected | < 50 | ng/mL | | Norhydrocodone Confirmation by LC-MS/MS | Not Detected | < 50 | ng/mL | | 6MAM Confirmation by LC-MS/MS | Not Detected | < 10 | ng/mL |
|
| Compliance Remarks | This test was developed and its performance characteristics determined by PAML. The U.S. Food and Drug Administration (FDA) has not approved or cleared this test. However, FDA approval or clearance is currently not required for clinical use of this test. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions. PAML is authorized under Clinical Laboratory Improvement Amendments (CLIA) to perform high-complexity testing. |
| Notes | The LCOP9 offers definative results for 9 opiate compounds or metabolites. Concentration levels above the LOQ are reported quantitatively. |
1387